MCMCB Pro
E0737

E0737Transcutaneous tibial nerve stimulator, controlled by phone application

HCPCSActiveBETOS Z2

E0737 is a HCPCS Level II code for transcutaneous tibial nerve stimulator, controlled by phone application. It belongs to the Durable Medical Equipment section. Medicare does not pay it — see the coverage note below before you bill it.

Medicare coverage: Non-covered by statute

Excluded from coverage by the Social Security Act itself, not by a policy decision. No documentation and no appeal changes this one — an ABN is the relevant conversation.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Medically Unlikely Edits — units per day

The most units of E0737 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

DME supplier
1 unit
MAI 2 — Date of Service Edit: Policy · Code Descriptor / CPT Instruction

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for E0737

Long descriptor
Transcutaneous tibial nerve stimulator, controlled by phone application

The official wording. This is what the code means.

Short descriptor
Transcut tibial stim by app

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2024

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to E0737

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If E0737 is not quite right, the correct code is very often within a few positions of it.

  • E0721Transcutaneous electrical nerve stimulator for nerves in the auricular region
  • E0730Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation
  • E0731Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric)
  • E0732Cranial electrotherapy stimulation (ces) system, any type
  • E0733Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve
  • E0734External upper limb tremor stimulator of the peripheral nerves of the wrist
  • E0735Non-invasive vagus nerve stimulator
  • E0736Transcutaneous tibial nerve stimulator
  • E0738Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories
  • E0739Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors
  • E0740Non-implanted pelvic floor electrical stimulator, complete system
  • E0743External lower extremity nerve stimulator for restless legs syndrome, each
  • E0744Neuromuscular stimulator for scoliosis
  • E0745Neuromuscular stimulator, electronic shock unit
  • E0746Electromyography (emg), biofeedback device
  • E0747Osteogenesis stimulator, electrical, non-invasive, other than spinal applications

Questions about E0737

What is HCPCS code E0737?

E0737 is a HCPCS Level II code for transcutaneous tibial nerve stimulator, controlled by phone application. It sits in the Durable Medical Equipment section.

Does Medicare cover E0737?

The CMS HCPCS file marks E0737 as "Non-covered by statute". Excluded from coverage by the Social Security Act itself, not by a policy decision. No documentation and no appeal changes this one — an ABN is the relevant conversation.

HCPCS Level II2026Q3-Jul· effective July 1, 2026